ZEAL Stock Summary

• Of note is the ratio of Zealand Pharma A's sales and general administrative expense to its total operating expenses; only 0.23% of US stocks have a lower such ratio.
• The ratio of debt to operating expenses for Zealand Pharma A is higher than it is for about only 0.37% of US stocks.
• With a year-over-year growth in debt of -100%, Zealand Pharma A's debt growth rate surpasses merely 0% of about US stocks.
• If you're looking for stocks that are quantitatively similar to Zealand Pharma A, a group of peers worth examining would be TECK, IPWR, LOV, AKRX, and REGI.
• ZEAL's SEC filings can be seen here. And to visit Zealand Pharma A's official web site, go to www.zealandpharma.com.